Rare diseases
Investigational molecules
Locations
459 conditions with trials, the busiest first
1 397 trials across Europe, recruiting first
Study on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
AustriaStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on Fenebrutinib and Teriflunomide for Adults with Relapsing Multiple Sclerosis
FinlandStudy on the Long-Term Safety of GTX-102 for Patients with Angelman Syndrome
FranceStudy on the Effects and Safety of Prasinezumab for Patients with Early Parkinson's Disease
AustriaStudy on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler
CzechiaStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
AustriaStudy on the Long-Term Safety of Brivaracetam for Children and Young Adults with Childhood or Juvenile Absence Epilepsy
ItalyStudy on the Effects of Cardiodoron Dilution for Patients with Functional Cardiovascular Disorders
GermanyLong-term Safety and Efficacy Study of Elivaldogene Autotemcel for Patients with Cerebral Adrenoleukodystrophy
FranceStudy on the Effects of Casimersen and Golodirsen for Patients with Duchenne Muscular Dystrophy Amenable to Exon 45 or 53 Skipping
BelgiumStudy on Lecanemab and Drug Combination for Patients with Early Onset Alzheimer's Disease Due to Genetic Mutation
GermanyThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
